|
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in …
StreetInsider.com GlaxoSmithKline (NYSE: GSK) severe asthma drug, mepolizumab, is effective in adults, FDA panel says, according to Bloomberg. UPDATE – Last November, Glaxo announced that it filed regulatory submissions in the USA and Europe for mepolizumab for … |
View full post on asthma – Google News